Panacea Global Inc (HOML) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
330 HIGHWAY 7 EAST RICHMOND HILL, ON L4B 3P8 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 9/30/2014 MRQ | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 2,309,563 | 109,151 | |||
| Cash and cash equivalents | 2,309,563 | 109,151 | |||
| Other current assets | 49,040 | ✕ | |||
| Prepaid expense and other current assets | ✕ | ✕ | 73,226 | ||
| Total current assets: | 2,358,603 | 182,377 | |||
| Noncurrent Assets | |||||
| Property, plant and equipment | 78,236 | 89,384 | |||
| Long-term investments and receivables | 911,672 | 912,576 | |||
| Long-term investments | 911,672 | 912,576 | |||
| Intangible assets, net (including goodwill) | 50,000,000 | 50,000,000 | |||
| Intangible assets, net (excluding goodwill) | 50,000,000 | 50,000,000 | |||
| Total noncurrent assets: | 50,989,908 | 51,001,960 | |||
| TOTAL ASSETS: | 53,348,511 | 51,184,337 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities, including: | 390,074 | 293,926 | |||
| Other undisclosed accounts payable and accrued liabilities | 390,074 | 293,926 | |||
| Debt | 574,211 | 1,562,500 | |||
| Due to related parties | 720,209 | 943,019 | |||
| Total current liabilities: | 1,684,494 | 2,799,445 | |||
| Noncurrent Liabilities | |||||
| Other undisclosed liabilities | 1,000,000 | 1,000,000 | |||
| Total liabilities: | 2,684,494 | 3,799,445 | |||
| Equity | |||||
| Equity, attributable to parent, including: | 50,664,017 | 47,384,892 | |||
| Common stock | 105,998 | 95,364 | |||
| Additional paid in capital | 55,145,783 | 50,389,417 | |||
| Accumulated other comprehensive income | 133,206 | 89,111 | |||
| Warrants and rights outstanding | 4,700,000 | ||||
| Other undisclosed equity, attributable to parent | (4,720,970) | (7,889,000) | |||
| Total equity: | 50,664,017 | 47,384,892 | |||
| TOTAL LIABILITIES AND EQUITY: | 53,348,511 | 51,184,337 | |||
Income Statement (P&L) (USD)
| 9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Operating expenses | (1,460,016) | (965,617) | ||
| Other operating income, net (Other Expenses) | 945,482 | 502,411 | ||
| Other undisclosed operating loss | (977,566) | (533,867) | ||
| Operating loss: | (1,492,100) | (997,073) | ||
| Loss from continuing operations before equity method investments, income taxes: | (1,492,100) | (997,073) | ||
| Loss from equity method investments | (904) | (3,184) | ||
| Other undisclosed income from continuing operations before income taxes | 51,504 | 31,456 | ||
| Loss from continuing operations before income taxes: | (1,441,500) | (968,801) | ||
| Income tax benefit | 71,050 | 46,601 | ||
| Loss from continuing operations: | (1,370,450) | (922,200) | ||
| Loss before gain (loss) on sale of properties: | (1,370,450) | (922,200) | ||
| Other undisclosed net loss | (161,520) | |||
| Net loss: | (1,531,970) | (922,200) | ||
| Other undisclosed net loss attributable to parent | (93,202) | |||
| Net loss available to common stockholders, diluted: | (1,531,970) | (1,015,402) | ||
Comprehensive Income (USD)
| 9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|
| Net loss: | (1,531,970) | (922,200) | ||
| Comprehensive loss: | (1,531,970) | (922,200) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 44,095 | (444) | ||
| Comprehensive loss, net of tax, attributable to parent: | (1,487,875) | (922,644) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.